Route-dependent Bioavailability

Route-Dependent Bioavailability is the proportion of an administered drug that reaches systemic circulation in its unchanged form, differentiating by the specific anatomical pathway through which the drug is introduced into the body.

19

Publications

833

Citations

66

Authors

25

Institutions

Publications per year

2017–2026

1

Authors

66

  1. LZ
    Leslie Z. Benet

    University of California, San Francisco, United States

    1 publications · 52 citations

    2

    h-index

  2. AG
    A. Gérardin

    Novartis (Switzerland), Switzerland

    2 publications · 59 citations

    2

    h-index

  3. PM
    Philipp Müller

    Novartis (Switzerland), Switzerland

    2 publications · 59 citations

    2

    h-index

  4. AR
    Amy Racine

    Novartis (Switzerland), Switzerland

    2 publications · 59 citations

    2

    h-index

  5. PI
    P Imhof

    Novartis (Switzerland), Switzerland

    2 publications · 59 citations

    2

    h-index

1–5 of 66

Venues

  1. PubMed

    Repository · 4 publications · 98 citations

    4

    h-index

  2. International Journal of Pharmaceutics

    2 publications · 49 citations

    2

    h-index

  3. Contraception

    1 publications · 25 citations

    1

    h-index

  4. The American Journal of Cardiology

    1 publications · 52 citations

    1

    h-index

  5. Journal of Pharmaceutical Sciences

    1 publications · 265 citations

    1

    h-index

1–5